Sign up
Pharma Capital
EPIC: SEEL
Market: NASDAQ
52-week High/Low: $14.40 / $1.33
Sector: Pharma & Biotech
Market Cap: $46.60M

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system (CNS) disorders and other rare disorders. The Company’s robust portfolio includes several late-stage clinical assets targeting psychiatric and movement disorders,...

Seelos Therapeutics

seelostherapeutics.com

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Seelos Therapeutics

View full SEEL profile View Profile
View All

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.